🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12475+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12475 recruiting trials

Phase 2RecruitingNCT06190067

Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma

👨‍⚕️ Liren Qian, PhD, Navy General Hospital, Beijing📍 1 site📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT05943535

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

🏥 United Therapeutics📍 150 sites📅 Started Oct 2023View details ↗
NARecruitingNCT05942885

Hypnosis: a Path to Appeasement

👨‍⚕️ Thomas BERT, Hospices Civils de Lyon📍 1 site📅 Started Oct 2023View details ↗
Phase 1RecruitingNCT06316076

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

🏥 RenJi Hospital📍 1 site📅 Started Oct 2023View details ↗
EARLY_Phase 1RecruitingNCT06125847

NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia

👨‍⚕️ Zuyi Yuan, M.D., First Affiliated Hospital of Xian Jiaotong University📍 1 site📅 Started Oct 2023View details ↗
Phase 1, PHASE2RecruitingNCT05994534

PK and PD Study of NPI-001 and Cysteamine Bitartrate

👨‍⚕️ Hugh McCarthy, PhD, FRACP, Sydney Children's Health Network📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT06127641

Rehabilitation of People With Post-tuberculosis Lung Disease

🏥 Centro Universitário Augusto Motta📍 2 sites📅 Started Oct 2023View details ↗
Phase 1RecruitingNCT06105151

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

👨‍⚕️ Gang Wang, Beijing Anding Hospital of Capital Medical University📍 1 site📅 Started Oct 2023View details ↗
Phase 1, PHASE2RecruitingNCT05978284

Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

👨‍⚕️ Qiming Wang, Henan Cancer Hospital📍 1 site📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT05918302

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

👨‍⚕️ Jaume Capdevila, M.D. Ph.D., Hospital Vall d'Hebron📍 27 sites📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT05440864

Durvalumab and Tremelimumab in Resectable HCC

👨‍⚕️ Gonzalo Sapisochin, MD, Univeristy Health Network📍 3 sites📅 Started Oct 2023View details ↗
Phase 1RecruitingNCT06026319

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

👨‍⚕️ Matthew Frigault, MD, Massachusetts General Hospital📍 1 site📅 Started Oct 2023View details ↗
Enrolling by InvitationNCT06227962

Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors

👨‍⚕️ Annette C. Moll, MD PhD, Amsterdam University Medical Center📍 1 site📅 Started Oct 2023View details ↗
Phase 1RecruitingNCT05834244

A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)

👨‍⚕️ Abhishek Maiti, MD, M.D. Anderson Cancer Center📍 2 sites📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT05674994

Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

👨‍⚕️ Jean-Marc NACCACHE, Fondation Hôpital Saint-Joseph📍 29 sites📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT06004856

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

🏥 Beijing InnoCare Pharma Tech Co., Ltd.📍 45 sites📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT05892614

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

👨‍⚕️ Lisa Carey, aTyr Pharma, Inc.📍 15 sites📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT06190639

A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC

🏥 Zhejiang Cancer Hospital📍 1 site📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT06904014

Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC

🏥 Lei ZHAO📍 1 site📅 Started Oct 2023View details ↗
RecruitingNCT06096766

The Correlation Between Ovarian Function and Serum Biomarkers

👨‍⚕️ Yun Shi, PhD, Dongzhimen Hospital of Beijing University of Chinese Medicine📍 1 site📅 Started Oct 2023View details ↗
← PreviousPage 366 of 624Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →